|
US949A
(en)
|
|
1838-09-27 |
|
Improvement in roller cotton-gins for ginning long-staple and other kinds of cotton |
|
US510A
(en)
|
|
1837-12-07 |
|
soeel |
|
US5863A
(en)
|
|
1848-10-17 |
|
Matthias p |
|
US5861A
(en)
|
|
1848-10-17 |
|
Locking umbrella and parasol |
|
US5033252A
(en)
|
1987-12-23 |
1991-07-23 |
Entravision, Inc. |
Method of packaging and sterilizing a pharmaceutical product
|
|
US5052558A
(en)
|
1987-12-23 |
1991-10-01 |
Entravision, Inc. |
Packaged pharmaceutical product
|
|
GB8827305D0
(en)
|
1988-11-23 |
1988-12-29 |
British Bio Technology |
Compounds
|
|
US5323907A
(en)
|
1992-06-23 |
1994-06-28 |
Multi-Comp, Inc. |
Child resistant package assembly for dispensing pharmaceutical medications
|
|
DE4239169A1
(de)
|
1992-11-21 |
1994-05-26 |
Merck Patent Gmbh |
Cyclobutan - Benzol - Derivate
|
|
US5455258A
(en)
|
1993-01-06 |
1995-10-03 |
Ciba-Geigy Corporation |
Arylsulfonamido-substituted hydroxamic acids
|
|
US5863949A
(en)
|
1995-03-08 |
1999-01-26 |
Pfizer Inc |
Arylsulfonylamino hydroxamic acid derivatives
|
|
CA2218503C
(en)
|
1995-04-20 |
2001-07-24 |
Pfizer Inc. |
Arylsulfonyl hydroxamic acid derivatives
|
|
DK0780386T3
(da)
|
1995-12-20 |
2003-02-03 |
Hoffmann La Roche |
Matrixmetalloproteaseinhibitorer
|
|
EP0818442A3
(en)
|
1996-07-12 |
1998-12-30 |
Pfizer Inc. |
Cyclic sulphone derivatives as inhibitors of metalloproteinases and of the production of tumour necrosis factor
|
|
EP0923585B1
(en)
|
1996-07-18 |
2002-05-08 |
Pfizer Inc. |
Phosphinate based inhibitors of matrix metalloproteases
|
|
US5782605A
(en)
|
1996-07-19 |
1998-07-21 |
Andritz Sprout-Bauer, Inc. |
Impeller for separating a conveyed stream of material
|
|
EP0922030A1
(en)
|
1996-08-23 |
1999-06-16 |
Pfizer Inc. |
Arylsulfonylamino hydroxamic acid derivatives
|
|
US5914251A
(en)
|
1996-10-22 |
1999-06-22 |
Amgen Inc. |
Nucleic acid molecules encoding placental-derived growth factors
|
|
US5866562A
(en)
|
1996-10-25 |
1999-02-02 |
Bayer Aktiengesellschaft |
Ring-bridged bis-quinolines
|
|
US6077864A
(en)
|
1997-01-06 |
2000-06-20 |
Pfizer Inc. |
Cyclic sulfone derivatives
|
|
HUP0000852A2
(hu)
|
1997-02-03 |
2001-05-28 |
Pfizer Products Inc. |
Aril-szulfonil-amino-hidroxámsav-származékok, valamint e vegyületeket tartalmazó gyógyászati készítmények
|
|
JP2000507975A
(ja)
|
1997-02-07 |
2000-06-27 |
ファイザー・インク |
Ｎ−ヒドロキシ−β−スルホニルプロピオンアミド誘導体類及びそれらのマトリックスメタロプロテイナーゼ阻害薬としての使用
|
|
NZ336836A
(en)
|
1997-02-11 |
2001-02-23 |
Pfizer |
Arylsulfonyl hydroxamic acid derivatives suitable for a broad range of medicinal treatments
|
|
JPH10330377A
(ja)
|
1997-06-02 |
1998-12-15 |
Kyowa Hakko Kogyo Co Ltd |
ピペリジン誘導体
|
|
TR200000368T2
(tr)
|
1997-08-08 |
2000-07-21 |
Pfizer Products Inc. |
Ariloksiariarilsülfonilamino hidroksamik asit türevleri.
|
|
GB9725782D0
(en)
|
1997-12-05 |
1998-02-04 |
Pfizer Ltd |
Therapeutic agents
|
|
US6708022B1
(en)
|
1997-12-22 |
2004-03-16 |
Renesas Technology Corporation |
Power amplification system and mobile radio communication terminal
|
|
GB9801690D0
(en)
|
1998-01-27 |
1998-03-25 |
Pfizer Ltd |
Therapeutic agents
|
|
US6479487B1
(en)
|
1998-02-26 |
2002-11-12 |
Aventis Pharmaceuticals Inc. |
6, 9-disubstituted 2-[trans-(4-aminocyclohexyl)amino] purines
|
|
JP4462654B2
(ja)
|
1998-03-26 |
2010-05-12 |
ソニー株式会社 |
映像素材選択装置及び映像素材選択方法
|
|
PA8469401A1
(es)
|
1998-04-10 |
2000-05-24 |
Pfizer Prod Inc |
Derivados biciclicos del acido hidroxamico
|
|
PA8469501A1
(es)
|
1998-04-10 |
2000-09-29 |
Pfizer Prod Inc |
Hidroxamidas del acido (4-arilsulfonilamino)-tetrahidropiran-4-carboxilico
|
|
PA8474101A1
(es)
|
1998-06-19 |
2000-09-29 |
Pfizer Prod Inc |
Compuestos de pirrolo [2,3-d] pirimidina
|
|
EP1004578B1
(en)
|
1998-11-05 |
2004-02-25 |
Pfizer Products Inc. |
5-oxo-pyrrolidine-2-carboxylic acid hydroxamide derivatives
|
|
US6511993B1
(en)
|
1999-06-03 |
2003-01-28 |
Kevin Neil Dack |
Metalloprotease inhibitors
|
|
GB9912961D0
(en)
|
1999-06-03 |
1999-08-04 |
Pfizer Ltd |
Metalloprotease inhibitors
|
|
EP1081137A1
(en)
|
1999-08-12 |
2001-03-07 |
Pfizer Products Inc. |
Selective inhibitors of aggrecanase in osteoarthritis treatment
|
|
US20070208087A1
(en)
|
2001-11-02 |
2007-09-06 |
Sanders Virginia J |
Compounds, compositions and methods for the treatment of inflammatory diseases
|
|
EP2048142A3
(en)
|
2001-04-26 |
2009-04-22 |
Eisai R&D Management Co., Ltd. |
Nitrogen-containing condensed cyclic compound having a pyrazolyl group as a substituent group and pharmaceutical composition thereof
|
|
CN101100472A
(zh)
|
2001-04-30 |
2008-01-09 |
美国拜尔公司 |
4-氨基-5,6-取代的噻吩并[2,3-d]嘧啶化合物及其应用
|
|
WO2003022214A2
(en)
|
2001-09-06 |
2003-03-20 |
Millennium Pharmaceuticals, Inc. |
Piperazine and homopiperazine compounds
|
|
WO2004030671A2
(en)
|
2002-10-02 |
2004-04-15 |
Merck Patent Gmbh |
Use of 4-amino-quinazolines as anti cancer agents
|
|
AU2003255482A1
(en)
|
2002-10-02 |
2004-04-23 |
Merck Patent Gmbh |
Use of 4 amino-quinazolines as anti cancer agents
|
|
US20050222175A1
(en)
|
2004-03-31 |
2005-10-06 |
Dhanoa Dale S |
New piperidinylamino-thieno[2,3-D] pyrimidine compounds
|
|
BRPI0408988A
(pt)
|
2003-03-31 |
2006-03-28 |
Predix Pharmaceuticals Holding |
composto de piperidinilamino-tieno[2,3-d]pirimidina
|
|
US7612078B2
(en)
|
2003-03-31 |
2009-11-03 |
Epix Delaware, Inc. |
Piperidinylamino-thieno[2,3-D] pyrimidine compounds
|
|
EP1663962A4
(en)
|
2003-08-22 |
2007-08-22 |
Dendreon Corp |
COMPOSITIONS AND METHODS FOR TREATING A DISEASE ASSOCIATED WITH TRP-P8 EXPRESSION
|
|
US20050123906A1
(en)
|
2003-11-06 |
2005-06-09 |
Rana Tariq M. |
Protein modulation
|
|
WO2006014420A1
(en)
|
2004-07-06 |
2006-02-09 |
Angion Biomedica Corporation |
Quinazoline modulators of hepatocyte growth factor / c-met activity for the treatment of cancer
|
|
ES2371774T3
(es)
|
2005-06-03 |
2012-01-10 |
Abbott Laboratories |
Derivados de ciclobutilamina.
|
|
US20060281771A1
(en)
|
2005-06-10 |
2006-12-14 |
Baumann Christian A |
Synergistic modulation of flt3 kinase using aminoquinoline and aminoquinazoline kinase modulators
|
|
US20060281769A1
(en)
|
2005-06-10 |
2006-12-14 |
Baumann Christian A |
Synergistic modulation of flt3 kinase using thienopyrimidine and thienopyridine kinase modulators
|
|
US20090221559A1
(en)
|
2005-09-02 |
2009-09-03 |
Jean-Francois Bonfanti |
Benzodiazepines as hcv inhibitors
|
|
JP5456315B2
(ja)
|
2005-09-19 |
2014-03-26 |
メルク パテント ゲゼルシャフト ミット ベシュレンクテル ハフツング |
シクロブタンおよびスピロ［３．３］ヘプタン化合物類
|
|
FR2891829A1
(fr)
|
2005-10-12 |
2007-04-13 |
Sanofi Aventis Sa |
Derives de la 4-amino-quinazoline, leur preparation et leur application en therapeutique
|
|
ATE541844T1
(de)
|
2005-12-21 |
2012-02-15 |
Abbott Lab |
Antivirale verbindungen
|
|
CA2651898A1
(en)
|
2006-04-07 |
2007-10-18 |
Develogen Aktiengesellschaft |
Thienopyrimidines having mnk1/mnk2 inhibiting activity for pharmaceutical compositions
|
|
EP1903044A1
(en)
|
2006-09-14 |
2008-03-26 |
Novartis AG |
Adenosine Derivatives as A2A Receptor Agonists
|
|
WO2008070303A2
(en)
|
2006-10-19 |
2008-06-12 |
The University Of Chicago |
Therapeutics to inhibit mll-menin interaction for treating leukemia
|
|
EP1947103A1
(en)
|
2007-01-22 |
2008-07-23 |
4Sc Ag |
Aryloxypropanolamines, methods of preparation thereof and use of aryloxypropanolamines as medicaments
|
|
WO2008099019A1
(en)
|
2007-02-16 |
2008-08-21 |
Tibotec Pharmaceuticals Ltd. |
6-hydroxy-dibenzodiazepinones useful as hepatitis c virus inhibitors
|
|
FR2913017A1
(fr)
|
2007-02-23 |
2008-08-29 |
Cerep Sa |
Derives de piperidine et piperazine comme agents anti-neoplasiques ou inhibiteurs de proliferation cellulaire
|
|
ATE496022T1
(de)
|
2007-03-19 |
2011-02-15 |
Council Scient Ind Res |
Anthranilsäure-derivat als antikrebswirkstoff und verfahren zur herstellung davon
|
|
WO2008135232A1
(en)
|
2007-05-02 |
2008-11-13 |
Riccardo Cortese |
Use and compositions of purine derivatives for the treatment of proliferative disorders
|
|
EP2148944A1
(en)
|
2007-05-25 |
2010-02-03 |
Burnham Institute for Medical Research |
Inhibitors of thapsigargin-induced cell death
|
|
WO2009017838A2
(en)
|
2007-08-01 |
2009-02-05 |
Exelixis, Inc. |
Combinations of jak-2 inhibitors and other agents
|
|
WO2009064388A2
(en)
|
2007-11-09 |
2009-05-22 |
Liu Jun O |
Inhibitors of human methionine aminopeptidase 1 and methods of treating disorders
|
|
AU2008345225A1
(en)
|
2007-12-21 |
2009-07-09 |
University Of Rochester |
Method for altering the lifespan of eukaryotic organisms
|
|
JP2011523420A
(ja)
|
2008-05-22 |
2011-08-11 |
アラーガン インコーポレイテッド |
Ｃｘｃｒ４受容体において活性を有する二環式化合物
|
|
DE102008027574A1
(de)
|
2008-06-10 |
2009-12-17 |
Merck Patent Gmbh |
Neue Pyrrolidinderivate als MetAP-2 Inhibitoren
|
|
CN102203067B
(zh)
|
2008-08-25 |
2014-01-15 |
Irm责任有限公司 |
Hedgehog通路调节剂
|
|
AR073739A1
(es)
|
2008-09-10 |
2010-12-01 |
Kalypsys Inc |
Aminopirimidinas como inhibidores de los receptores de histamina
|
|
JP5690823B2
(ja)
|
2009-07-08 |
2015-03-25 |
レオ ファーマ アクティーゼルスカブ |
Ｊａｋ受容体およびタンパク質チロシンキナーゼ阻害薬としての複素環化合物
|
|
WO2011014128A1
(en)
|
2009-07-30 |
2011-02-03 |
National University Of Singapore |
Small molecule inhibitors of isoprenylcysteine carboxyl methyltransferase with potential anticancer activity
|
|
AU2010289321A1
(en)
|
2009-09-04 |
2012-04-05 |
The Regents Of The University Of Michigan |
Compositions and methods for treatment of leukemia
|
|
BR112012019561A2
(pt)
|
2010-02-22 |
2019-09-24 |
Merck Patent Gmbh |
hetarilamino naftiridinas
|
|
BR112013003864B1
(pt)
|
2010-08-20 |
2021-08-31 |
Hutchison Medipharma Limited |
Compostos de pirrolpirimidina, composição e uso dos mesmos
|
|
CN103391939B
(zh)
|
2010-12-03 |
2016-03-09 |
Epizyme股份有限公司 |
作为表观遗传酶调节剂的经取代的嘌呤和7-氮杂嘌呤化合物
|
|
EP2646454B1
(en)
|
2010-12-03 |
2015-07-08 |
Epizyme, Inc. |
7-deazapurine modulators of histone methyltransferase, and methods of use thereof
|
|
US9394310B2
(en)
|
2010-12-03 |
2016-07-19 |
Epizyme, Inc. |
Carbocycle-substituted purine and 7-deazapurine compounds
|
|
AU2011341441A1
(en)
|
2010-12-03 |
2013-06-20 |
Epizyme, Inc. |
Modulators of histone methyltransferase, and methods of use thereof
|
|
WO2013019966A1
(en)
|
2011-08-04 |
2013-02-07 |
Allergan, Inc. |
Aromatic bycyclic derivatives as cxcr4 receptor modulators
|
|
GB201114212D0
(en)
|
2011-08-18 |
2011-10-05 |
Ucb Pharma Sa |
Therapeutic agents
|
|
AR090037A1
(es)
|
2011-11-15 |
2014-10-15 |
Xention Ltd |
Derivados de tieno y/o furo-pirimidinas y piridinas inhibidores de los canales de potasio
|
|
CN103833759A
(zh)
|
2012-11-23 |
2014-06-04 |
华东理工大学 |
作为blk、flt3抑制剂的蝶啶酮衍生物及其应用
|
|
WO2014026198A1
(en)
|
2012-08-10 |
2014-02-13 |
Epizyme, Inc. |
Inhibitors of protein methyltransferase dot1l and methods of use thereof
|
|
US20140100184A1
(en)
|
2012-08-31 |
2014-04-10 |
Baylor College Of Medicine |
Selective inhibitors of histone methyltransferase dot1l
|
|
EP2892536B1
(en)
|
2012-09-06 |
2019-12-18 |
Epizyme, Inc. |
Method of treating leukemia
|
|
GB201217704D0
(en)
|
2012-10-03 |
2012-11-14 |
Ucb Pharma Sa |
Therapeutic agents
|
|
JP2016510316A
(ja)
|
2012-12-21 |
2016-04-07 |
エピザイム，インコーポレイティド |
白血病の治療に使用するためのｄｏｔ１ｌ阻害剤
|
|
BR112015016282A2
(en)
*
|
2013-01-07 |
2017-07-11 |
Arog Pharmaceuticals, Inc. |
crenolanib for treatment of mutated flt3 proliferative disorders
|
|
EP2968285A4
(en)
|
2013-03-13 |
2016-12-21 |
Flatley Discovery Lab |
COMPOUNDS AND METHODS FOR THE TREATMENT OF CYSTIC FIBROSIS
|
|
AU2014249233A1
(en)
*
|
2013-03-13 |
2015-09-24 |
The Regents Of The University Of Michigan |
Compositions comprising thienopyrimidine and thienopyridine compounds and methods of use thereof
|
|
US9212180B2
(en)
|
2013-06-12 |
2015-12-15 |
The Regents Of The University Of Michigan |
Menin-MLL inhibitors and methods of use thereof
|
|
US10407732B2
(en)
|
2013-08-02 |
2019-09-10 |
Memorial Sloan Kettering Cancer Center |
Methods for the detection and treatment of leukemias that are responsive to DOT1L inhibition
|
|
MX358346B
(es)
|
2014-04-04 |
2018-08-15 |
Syros Pharmaceuticals Inc |
Inhibidores de la quinasa dependiente de ciclina 7 (cdk7).
|
|
JP2017514505A
(ja)
|
2014-05-07 |
2017-06-08 |
アンスティチュ ナショナル ドゥ ラ サンテ エ ドゥ ラ ルシェルシュ メディカル |
急性骨髄性白血病の新規バイオマーカー
|
|
US20170119769A1
(en)
|
2014-06-10 |
2017-05-04 |
The Trustees Of The University Of Pennsylvania |
Scaffolds for inhibitors of menin-mll interactions
|
|
US20170232030A1
(en)
*
|
2014-08-13 |
2017-08-17 |
Epizyme, Inc. |
Combination therapy for treating cancer
|
|
WO2016025649A1
(en)
|
2014-08-13 |
2016-02-18 |
Celgene Avilomics Research, Inc. |
Combinations of an erk inhibitor and a dot1l inhibitor and related methods
|
|
USRE49687E1
(en)
|
2014-09-09 |
2023-10-10 |
The Regents Of The University Of Michigan |
Thienopyrimidine and thienopyridine compounds and methods of use thereof
|
|
US10526341B2
(en)
|
2014-11-19 |
2020-01-07 |
Memorial Sloan-Kettering Cancer Center |
Thienopyrimidines and uses thereof
|
|
TWI703150B
(zh)
|
2015-06-04 |
2020-09-01 |
美商庫拉腫瘤技術股份有限公司 |
用於抑制ｍｅｎｉｎ及ｍｌｌ蛋白之交互作用的方法及組合物
|
|
WO2016197027A1
(en)
|
2015-06-04 |
2016-12-08 |
Kura Oncology, Inc. |
Methods and compositions for inhibiting the interaction of menin with mll proteins
|
|
CA2998042C
(en)
|
2015-09-14 |
2022-07-05 |
Brunangelo Falini |
Dactinomycin compositions and methods for the treatment of acute myeloid leukemia
|
|
BR112018012707A2
(pt)
|
2015-12-22 |
2019-01-29 |
Vitae Pharmaceuticals Inc |
inibidores da interação de menin-mll
|
|
AU2017212572A1
(en)
|
2016-01-26 |
2018-08-23 |
Memorial Sloan-Kettering Cancer Center |
Targeting chromatin regulators inhibits leukemogenic gene expression in NPM1 mutant leukemia
|
|
WO2017161028A1
(en)
|
2016-03-16 |
2017-09-21 |
Kura Oncology, Inc. |
Substituted inhibitors of menin-mll and methods of use
|
|
US10752639B2
(en)
*
|
2016-03-16 |
2020-08-25 |
Kura Oncology, Inc. |
Bridged bicyclic inhibitors of menin-MLL and methods of use
|
|
CN109415337B
(zh)
|
2016-05-02 |
2022-01-18 |
密执安大学评议会 |
作为多发性内分泌腺瘤蛋白抑制剂的哌啶
|
|
WO2017207387A1
(en)
|
2016-05-31 |
2017-12-07 |
Bayer Pharma Aktiengesellschaft |
Spiro condensed azetidine derivatives as inhibitors of the menin-mml1 interaction
|
|
ES2831084T3
(es)
|
2016-06-10 |
2021-06-07 |
Vitae Pharmaceuticals Inc |
Inhibidores de la interacción menina-MLL
|
|
JP2019518063A
(ja)
|
2016-06-20 |
2019-06-27 |
クラ オンコロジー， インコーポレイテッド |
Ｅｒｋ阻害剤を用いた扁平上皮細胞癌の処置
|
|
CA2937896A1
(en)
|
2016-08-02 |
2018-02-02 |
Universite De Montreal |
Use of mubritinib for the treatment of poor prognosis acute myeloid leukemia
|
|
WO2018024602A1
(en)
|
2016-08-04 |
2018-02-08 |
Bayer Aktiengesellschaft |
2,7-diazaspiro[4.4]nonanes
|
|
CA3033239A1
(en)
|
2016-09-14 |
2018-03-22 |
Janssen Pharmaceutica Nv |
Spiro bicyclic inhibitors of menin-mll interaction
|
|
TWI753016B
(zh)
|
2016-09-14 |
2022-01-21 |
比利時商健生藥品公司 |
Menin-mll相互作用之稠合二環抑制劑
|
|
CN118359610A
(zh)
|
2016-09-16 |
2024-07-19 |
生命医药有限责任公司 |
Menin-mll相互作用的抑制剂
|
|
KR20180074792A
(ko)
|
2016-11-02 |
2018-07-03 |
아로그 파마슈티칼스, 인코퍼레이티드 |
돌연변이 연관된 flt3 돌연변이된 증식성 장애를 치료하기 위한 크레노라닙
|
|
WO2018106818A1
(en)
|
2016-12-07 |
2018-06-14 |
Kura Oncology, Inc. |
Methods of promoting beta cell proliferation
|
|
WO2018106820A1
(en)
|
2016-12-07 |
2018-06-14 |
Kura Oncology, Inc. |
Methods of promoting beta cell proliferation
|
|
JP7193460B2
(ja)
|
2016-12-23 |
2022-12-20 |
プレキシコン インコーポレーテッド |
Ｃｄｋ８調節およびその適応症のための化合物および方法
|
|
CN110691779B
(zh)
|
2017-03-24 |
2023-10-10 |
库拉肿瘤学公司 |
治疗血液系统恶性肿瘤和尤因肉瘤的方法
|
|
US11542248B2
(en)
|
2017-06-08 |
2023-01-03 |
Kura Oncology, Inc. |
Methods and compositions for inhibiting the interaction of menin with MLL proteins
|
|
TW201920170A
(zh)
|
2017-09-20 |
2019-06-01 |
美商庫拉腫瘤技術股份有限公司 |
經取代之menin-mll 抑制劑及使用方法
|
|
JP2022503792A
(ja)
|
2018-09-26 |
2022-01-12 |
クラ オンコロジー，インク． |
メニン阻害剤を用いた血液悪性腫瘍の処置
|